These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12702534)

  • 1. Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors.
    Castellano D; Hitt R; Ciruelos E; Cortés-Funes H; Colomer R
    Ann Oncol; 2003 May; 14(5):783-7. PubMed ID: 12702534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.
    Karampeazis A; Vamvakas L; Agelaki S; Kentepozidis N; Papadimitraki E; Gioulbasanis I; Vardakis N; Ignatiadis M; Mavroudis D; Georgoulias V
    Oncology; 2006; 71(5-6):347-53. PubMed ID: 17785992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
    Lorusso V; Crucitta E; Panza N; Silvestris N; Guida M; Carpagnano F; Mancarella S; Sambiasi D; De Lena M
    Ann Oncol; 2002 Dec; 13(12):1862-7. PubMed ID: 12453853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).
    Frasci G; Comella P; D'Aiuto G; Thomas R; Capasso I; Elmo M; Botti G; Cortino GR; Lapenta L; De Rosa V; Vallone P; Petrillo A; Comella G
    Ann Oncol; 2000 Mar; 11(3):367-71. PubMed ID: 10811508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.
    Gagel B; Piroth M; Pinkawa M; Reinartz P; Krohn T; Kaiser HJ; Stanzel S; Breuer C; Asadpour B; Schmachtenberg A; Eble MJ
    BMC Cancer; 2007 Jun; 7():112. PubMed ID: 17598906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Billings FT; Bradof JE; Baker M; Greco FA
    Cancer; 2001 Nov; 92(9):2391-8. PubMed ID: 11745295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
    Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KM; Shin DM; Papadimitrakopoulou VA; Kurie JM; Blumenschein G; Kies MS; Zinner R; Jung MS; Lu R; Lee JJ; Munden RF; Hong WK; Lee JS
    Cancer; 2002 Jul; 95(2):340-53. PubMed ID: 12124835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
    Herbst RS; Lynch C; Vasconcelles M; Teicher BA; Strauss G; Elias A; Anderson I; Zacarola P; Dang NH; Leong T; Salgia R; Skarin AT
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):151-9. PubMed ID: 11561781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.
    Chen YM; Perng RP; Yang KY; Liu TW; Tsai CM; Ming-Liu J; Whang-Peng J
    Chest; 2000 Jun; 117(6):1583-9. PubMed ID: 10858387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors.
    Yuan Y; Cohen DJ; Love E; Yaw M; Levinson B; Nicol SJ; Hochster HS
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):371-8. PubMed ID: 20978761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.
    Mariani G; Tagliabue P; Zucchinelli P; Brambilla C; Demicheli R; Villa E; Marchianò A; Valagussa P; Bonadonna G; Gianni L
    Breast Cancer Res Treat; 2001 Dec; 70(3):163-9. PubMed ID: 11804180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.
    Delord JP; Raymond E; Chaouche M; Ruffie P; Ducreux M; Faivre S; Boige V; Le Chevalier T; Rixe O; Baudin E; Pautier P; Rodier JM; Chouaki N; Escudier B; Kayitalire L; Armand JP
    Ann Oncol; 2000 Jan; 11(1):73-9. PubMed ID: 10690391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.
    Cole PD; Schwartz CL; Drachtman RA; de Alarcon PA; Chen L; Trippett TM
    J Clin Oncol; 2009 Mar; 27(9):1456-61. PubMed ID: 19224841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.
    Morabito A; Filippelli G; Palmeri S; Cascinu S; Ferraù F; Zagonel V; Gattuso D; Catalano V; Capaccetti B; Franciosi V; Accurso V; Scinto F; Gasparini G
    Breast Cancer Res Treat; 2003 Mar; 78(1):29-36. PubMed ID: 12611454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.
    Türkölmez K; Bedük Y; Baltaci S; Göğüş C; Göğüş O
    Eur Urol; 2003 Dec; 44(6):682-6. PubMed ID: 14644120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine and vinorelbine combination in platinum-sensitive recurrent ovarian cancer.
    Ferrero A; Logrippo V; Spanu PG; Fuso L; Perotto S; Daniele A; Zola P
    Int J Gynecol Cancer; 2009 Dec; 19(9):1529-34. PubMed ID: 19955931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer.
    Stathopoulos GP; Rigatos SK; Pergantas N; Tsavdarides D; Athanasiadis I; Malamos NA; Stathopoulos JG
    J Clin Oncol; 2002 Jan; 20(1):37-41. PubMed ID: 11773151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.
    Martoni A; Marino A; Sperandi F; Giaquinta S; Di Fabio F; Melotti B; Guaraldi M; Palomba G; Preti P; Petralia A; Artioli F; Picece V; Farris A; Mantovani L
    Eur J Cancer; 2005 Jan; 41(1):81-92. PubMed ID: 15617993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
    Mani S; Vogelzang NJ; Bertucci D; Stadler WM; Schilsky RL; Ratain MJ
    Cancer; 2001 Sep; 92(6):1567-76. PubMed ID: 11745236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.